Search
×
FR

Placeholder headline

This is just a placeholder headline

API STD 521: Guide for Pressure-relieving and Depressuring Systems – Edition 6

$

682

BUY NOW

Placeholder headline

This is just a placeholder headline

API STD 653: Tank Inspection, Repair, Alteration, and Reconstruction – Edition 4

$

507

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z662:19 – Oil and gas pipeline systems

$

1197

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z341 Series-18: Storage of hydrocarbons in underground formations

$

878

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z246.2-14 – Emergency preparedness and response for petroleum and natural gas industry systems

$

596

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z341 Series:22 – Storage of hydrocarbons in underground formations

$

878

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z731-09 (R2014) – Emergency Preparedness and Response

$

177

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z662:23 – Oil and gas pipeline systems

$

1197

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA Z341 Series:26 – Storage of Hydrocarbons in underground formations

$

878

BUY NOW

Placeholder headline

This is just a placeholder headline

CSA B51:24 Boiler, Pressure Vessel, and Pressure Piping Code

$

389

BUY NOW

ISO 25539:2024

ISO 25539:2024 Cardiovascular implants – Endovascular devices – Part 3: Vena cava filters

CDN $422.00

SKU: 13e31c877e0d Category:

Description

This document specifies the requirements for the evaluation of vena cava filter systems (filters and delivery systems) and the requirements with respect to nomenclature, design attributes and information supplied by the manufacturer. Guidance for the development of in vitro test methods is included in Annex D. This document is intended to be used in conjunction with ISO 14630, which specifies general requirements for the performance of non-active surgical implants.

NOTE 1       Due to the variations in the design of implants covered by this document, and in some cases due to the emergence of novel types of such implants, acceptable standardized in vitro tests and clinical results are not always available. As further scientific and clinical data become available, a revision of this document will be necessary.

This document is applicable to vena cava filters intended to prevent symptomatic pulmonary embolism by capturing blood clots in the inferior vena cava (IVC). While this document can be useful with respect to filters implanted in other venous locations (e.g. superior vena cava, iliac veins), it does not specifically address the use of filters in other implantation sites.

This document is also applicable to permanent filters together with their associated delivery systems, optional filters that can be retrieved and their associated retrieval systems, and convertible filters and their associated conversion systems. While this document can be useful with respect to the evaluation of repositioning filters after chronic implantation, it does not specifically address filter repositioning.

This document is not applicable to

           temporary filters (e.g. tethered) that need to be removed after a defined period of time,

           issues associated with viable tissues and non-viable biological materials, and

           procedures and devices (e.g. venous entry needle) used prior to the vena cava filter procedure.

Although absorbable filters and filters with absorbable coatings are within the scope of this document, this document is not comprehensive with respect to the absorbable properties of these devices.

NOTE 2       Absorbable implants are covered in ISO/TS 17137.

Although coated filters and coated filter systems are within the scope of this document, this document is not comprehensive with respect to coatings.

NOTE 3       Vascular device-drug combination products are covered in ISO 12417-1 and some coating properties are covered in ISO 25539-4.

Edition

2

Published Date

2024-10-17

Status

PUBLISHED

Pages

99

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document specifies the requirements for the evaluation of vena cava filter systems (filters and delivery systems) and the requirements with respect to nomenclature, design attributes and information supplied by the manufacturer. Guidance for the development of in vitro test methods is included in Annex D. This document is intended to be used in conjunction with ISO 14630, which specifies general requirements for the performance of non-active surgical implants.

NOTE 1       Due to the variations in the design of implants covered by this document, and in some cases due to the emergence of novel types of such implants, acceptable standardized in vitro tests and clinical results are not always available. As further scientific and clinical data become available, a revision of this document will be necessary.

This document is applicable to vena cava filters intended to prevent symptomatic pulmonary embolism by capturing blood clots in the inferior vena cava (IVC). While this document can be useful with respect to filters implanted in other venous locations (e.g. superior vena cava, iliac veins), it does not specifically address the use of filters in other implantation sites.

This document is also applicable to permanent filters together with their associated delivery systems, optional filters that can be retrieved and their associated retrieval systems, and convertible filters and their associated conversion systems. While this document can be useful with respect to the evaluation of repositioning filters after chronic implantation, it does not specifically address filter repositioning.

This document is not applicable to

-           temporary filters (e.g. tethered) that need to be removed after a defined period of time,

-           issues associated with viable tissues and non-viable biological materials, and

-           procedures and devices (e.g. venous entry needle) used prior to the vena cava filter procedure.

Although absorbable filters and filters with absorbable coatings are within the scope of this document, this document is not comprehensive with respect to the absorbable properties of these devices.

NOTE 2       Absorbable implants are covered in ISO/TS 17137.

Although coated filters and coated filter systems are within the scope of this document, this document is not comprehensive with respect to coatings.

NOTE 3       Vascular device-drug combination products are covered in ISO 12417-1 and some coating properties are covered in ISO 25539-4.

Previous Editions

Can’t find what you are looking for?

Please contact us at: